Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
BT-20 | PLX-4720 | 0.0033113 | uM | 5 | 1250.00 | 675.75 | 2216.00 | 2082.50 | 1.0641 | 1.0780 |
BT-20 | Etoposide | 3.1623 | uM | 5 | 1250.00 | 675.75 | 944.00 | 2082.50 | 0.4533 | 0.2286 |
BT-20 | Etoposide | 0.31623 | uM | 5 | 1250.00 | 675.75 | 1743.00 | 2082.50 | 0.8370 | 0.7924 |
BT-20 | NVP-TAE684 | 0.0016596 | uM | 5 | 1250.00 | 675.75 | 1990.00 | 2082.50 | 0.9556 | 0.9448 |
BT-20 | Etoposide | 0.1 | uM | 5 | 1250.00 | 675.75 | 1955.00 | 2082.50 | 0.9388 | 0.9237 |
BT-20 | NVP-TAE684 | 0.031623 | uM | 5 | 1250.00 | 675.75 | 1998.00 | 2082.50 | 0.9594 | 0.9496 |
BT-20 | 0 | uM | 5 | 1250.00 | 675.75 | 1771.00 | 2082.50 | 0.8504 | 0.8101 | |
BT-20 | 0 | uM | 5 | 1250.00 | 675.75 | 1614.00 | 2082.50 | 0.7750 | 0.7095 | |
BT-20 | 0 | uM | 5 | 1250.00 | 675.75 | 1561.00 | 2082.50 | 0.7496 | 0.6747 | |
BT-20 | 0 | uM | 5 | 1250.00 | 675.75 | 1851.00 | 2082.50 | 0.8888 | 0.8600 | |
BT-20 | PLX-4720 | 19.9526 | uM | 5 | 1250.00 | 675.75 | 1231.00 | 2082.50 | 0.5911 | 0.4468 |
BT-20 | Nilotinib | 3.1623 | uM | 5 | 1250.00 | 675.75 | 2015.00 | 2082.50 | 0.9676 | 0.9598 |
BT-20 | Etoposide | 0.0033113 | uM | 5 | 1250.00 | 675.75 | 2276.00 | 2082.50 | 1.0929 | 1.1125 |
BT-20 | Etoposide | 0.031623 | uM | 5 | 1250.00 | 675.75 | 2328.00 | 2082.50 | 1.1179 | 1.1421 |
BT-20 | PLX-4720 | 0.031623 | uM | 5 | 1250.00 | 675.75 | 2403.00 | 2082.50 | 1.1539 | 1.1843 |
BT-20 | Nilotinib | 0.31623 | uM | 5 | 1250.00 | 675.75 | 2238.00 | 2082.50 | 1.0747 | 1.0907 |
BT-20 | NVP-TAE684 | 0.0033113 | uM | 5 | 1250.00 | 675.75 | 2438.00 | 2082.50 | 1.1707 | 1.2039 |
BT-20 | PLX-4720 | 0.1 | uM | 5 | 1250.00 | 675.75 | 2456.00 | 2082.50 | 1.1794 | 1.2139 |
BT-20 | NVP-TAE684 | 0.1 | uM | 5 | 1250.00 | 675.75 | 2294.00 | 2082.50 | 1.1016 | 1.1228 |
BT-20 | NVP-TAE684 | 0.01 | uM | 5 | 1250.00 | 675.75 | 2490.00 | 2082.50 | 1.1957 | 1.2327 |
BT-20 | 0 | uM | 5 | 1250.00 | 675.75 | 2425.00 | 2082.50 | 1.1645 | 1.1966 | |
BT-20 | Nilotinib | 0.01 | uM | 5 | 1250.00 | 675.75 | 2424.00 | 2082.50 | 1.1640 | 1.1961 |
BT-20 | 0 | uM | 5 | 1250.00 | 675.75 | 2423.00 | 2082.50 | 1.1635 | 1.1955 | |
BT-20 | NVP-TAE684 | 0.31623 | uM | 5 | 1250.00 | 675.75 | 2399.00 | 2082.50 | 1.1520 | 1.1821 |
BT-20 | Etoposide | 0.01 | uM | 5 | 1250.00 | 675.75 | 2462.00 | 2082.50 | 1.1822 | 1.2172 |